Examining issues regarding SCIG billing, coding and Medicare claims, along with questions about certification of homebound patients and products with new reimbursement codes.
As of April 2011, many cuts to healthcare spending are being proposed and expected.
Health Canada has approved Fluad, a seasonal flu vaccine manufactured by Novartis for adults aged 65 years and older. Fluad is the first seasonal flu vaccine in Canada to contain an adjuvant.
The House Judiciary Committee is working to pass medical tort reform legislation.
The U.S. Food and Drug Administration (FDA) has approved Benlysta (belimumab) to treat patients with active autoantibody positive lupus (systemic lupus erythematosus) who are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives and non steroidal anti-inflammatory drugs.